Literature DB >> 15823756

Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.

Hugo F Mendes1, Jacqueline van der Spuy, J Paul Chapple, Michael E Cheetham.   

Abstract

Retinitis pigmentosa (RP) is a group of retinal degenerative diseases that are characterised primarily by the loss of rod photoreceptor cells. Mutations in rhodopsin are the most common cause of autosomal-dominant RP (ADRP). Here, we propose a new classification for rhodopsin mutations based on their biochemical and cellular properties. Several different potential gain-of-function mechanisms for rhodopsin ADRP are described and discussed. Possible dominant-negative mechanisms, which affect the processing, translocation or degradation of wild-type rhodopsin, are also considered. Understanding the molecular and cellular consequences of rod-opsin mutations and the underlying disease mechanisms in ADRP are essential to develop future therapies for this class of retinal dystrophies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823756     DOI: 10.1016/j.molmed.2005.02.007

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  165 in total

1.  Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease.

Authors:  Benjamin M Scott; Steven K Chen; Nihar Bhattacharyya; Abdiwahab Y Moalim; Sergey V Plotnikov; Elise Heon; Sergio G Peisajovich; Belinda S W Chang
Journal:  Genetics       Date:  2018-12-04       Impact factor: 4.562

Review 2.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

3.  Structural, energetic, and mechanical perturbations in rhodopsin mutant that causes congenital stationary night blindness.

Authors:  Shiho Kawamura; Alejandro T Colozo; Lin Ge; Daniel J Müller; Paul S-H Park
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

4.  Molecular mechanisms of disease for mutations at Gly-90 in rhodopsin.

Authors:  Darwin Toledo; Eva Ramon; Mònica Aguilà; Arnau Cordomí; Juan J Pérez; Hugo F Mendes; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 5.  Ensemble of G protein-coupled receptor active states.

Authors:  P S-H Park
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Misfolded opsin mutants display elevated β-sheet structure.

Authors:  Lisa M Miller; Megan Gragg; Tae Gyun Kim; Paul S-H Park
Journal:  FEBS Lett       Date:  2015-09-07       Impact factor: 4.124

Review 7.  Chaperone machines for protein folding, unfolding and disaggregation.

Authors:  Helen Saibil
Journal:  Nat Rev Mol Cell Biol       Date:  2013-09-12       Impact factor: 94.444

8.  Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice.

Authors:  Haoyu Mao; Marina S Gorbatyuk; Brian Rossmiller; William W Hauswirth; Alfred S Lewin
Journal:  Hum Gene Ther       Date:  2012-03-28       Impact factor: 5.695

9.  Sector Retinitis Pigmentosa caused by mutations of the RHO gene.

Authors:  Ting Xiao; Ke Xu; Xiaohui Zhang; Yue Xie; Yang Li
Journal:  Eye (Lond)       Date:  2018-11-02       Impact factor: 3.775

Review 10.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.